Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng Michelle Xu

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Science China. Life Sciences|May 15, 2026
A new regulatory axis in cross-presentation: MS4A7 licenses cDC1s for effective CD8<sup>+</sup> T-cell primingYilin Liu, Meng Michelle Xu
Annual Review of Immunology|May 1, 2023
RNA Modification in the Immune SystemDali Han, Meng Michelle Xu
Trends in Immunology|January 19, 2016
The Role of Adaptive Immunity in the Efficacy of Targeted Cancer TherapiesMeng Michelle Xu, Yang Pu, Yuan Zhang, et al.
Molecular Cell|August 2, 2016
A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell PopulationsDali Han, Xingyu Lu, Alan H Shih, et al.
Science (New York, N.Y.)|January 18, 2020
<i>N</i> <sup>6</sup>-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcriptionJun Liu, Xiaoyang Dou, Chuanyuan Chen, et al.
Nature Medicine|September 1, 2015
CD47 blockade triggers T cell-mediated destruction of immunogenic tumorsXiaojuan Liu, Yang Pu, Kyle Cron, et al.
Haematologica|February 3, 2022
YTHDF3 modulates hematopoietic stem cells by recognizing RNA m<sup>6</sup>A modification on <i>Ccnd1</i>Xiaofei Zhang, Tingting Cong, Lei Wei, et al.
Immunity|August 13, 2017
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α SignalingMeng Michelle Xu, Yang Pu, Dali Han, et al.
Nature Cancer|February 5, 2022
Challenges and opportunities in 2021Leila Akkari, Stacey D Finley, Ping-Chih Ho, et al.
Nature|February 8, 2019
Anti-tumour immunity controlled through mRNA m<sup>6</sup>A methylation and YTHDF1 in dendritic cellsDali Han, Jun Liu, Chuanyuan Chen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Science China. Life Sciences|May 15, 2026
A new regulatory axis in cross-presentation: MS4A7 licenses cDC1s for effective CD8<sup>+</sup> T-cell primingYilin Liu, Meng Michelle Xu
Annual Review of Immunology|May 1, 2023
RNA Modification in the Immune SystemDali Han, Meng Michelle Xu
Trends in Immunology|January 19, 2016
The Role of Adaptive Immunity in the Efficacy of Targeted Cancer TherapiesMeng Michelle Xu, Yang Pu, Yuan Zhang, et al.
Molecular Cell|August 2, 2016
A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell PopulationsDali Han, Xingyu Lu, Alan H Shih, et al.
Science (New York, N.Y.)|January 18, 2020
<i>N</i> <sup>6</sup>-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcriptionJun Liu, Xiaoyang Dou, Chuanyuan Chen, et al.
Nature Medicine|September 1, 2015
CD47 blockade triggers T cell-mediated destruction of immunogenic tumorsXiaojuan Liu, Yang Pu, Kyle Cron, et al.
Haematologica|February 3, 2022
YTHDF3 modulates hematopoietic stem cells by recognizing RNA m<sup>6</sup>A modification on <i>Ccnd1</i>Xiaofei Zhang, Tingting Cong, Lei Wei, et al.
Immunity|August 13, 2017
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α SignalingMeng Michelle Xu, Yang Pu, Dali Han, et al.
Nature Cancer|February 5, 2022
Challenges and opportunities in 2021Leila Akkari, Stacey D Finley, Ping-Chih Ho, et al.
Nature|February 8, 2019
Anti-tumour immunity controlled through mRNA m<sup>6</sup>A methylation and YTHDF1 in dendritic cellsDali Han, Jun Liu, Chuanyuan Chen, et al.
Pageof 2